Furthermore, BNIP3 negative expression (P=0.024) was found to be significantly associated with poor survival in pancreatic cancer patients, irrespective of the clinical stage and lymph node metastasis (Supplementary Table 2). Here, BNIP3 is linked to metastatic malignant neoplasm in the lymph nodes.